Steven Kaufman talks with ONdrugDelivery about the world of autoinjectors, looking at the current status quo in the industry, using Portal Instruments’ PRIME Nexus™ smart reusable electromechanical autoinjector as a lens to bring into focus how things have changed and where they might be going.
Steven Kaufman discusses the rapidly evolving world of drug delivery and the future of self-injection.
In this exclusive interview, Kaufman highlights the tipping point the industry is facing, driven by a crucial need for sustainability and cost-effectiveness in an era of billions of disposable devices. He sheds light on the next generation of solutions, focusing on the rise of smart, reusable, electromechanical autoinjectors.
Using Portal Instruments' PRIME Nexus™ device as a key example, Kaufman explains how innovative platforms are designed to handle challenges like high-viscosity formulations and varying fill volumes, all while significantly reducing environmental impact. Learn how devices that prioritize the entire value chain, from manufacturing to elegant design and digital health integration, are setting the new standard for improved patient adherence and successful combination product programs.
The full article can be found in ONdrugDelivery.
March 2024 - Portal Instruments is pleased to be returning to Dana Point, California to share its drug delivery technology with investors and other emerging medtech companies at LSI USA '24. Patrick Anquetil, CEO, will be presenting the updates.
October 2024 - At the Partnership Opportunities in Drug Delivery (PODD) conference, Robert Hidalgo showcased Portal Instrument's latest advancements on its reusable, electro-mechanical drug delivery platform.
May 10, 2022 - Portal Instruments has been featured in Fierce Pharma. "Gerresheimer invests in Portal's needle-free drug delivery, teeing Takeda partner up to advance tech", showcases Gerresheimer's agreement with Portal to support the development of the needle-free drug delivery platform.
Please fill out the details below and we will get back to you shortly.